172 related articles for article (PubMed ID: 37093665)
21. The yield of dysplasia and serrated lesions in a single-centre tertiary inflammatory bowel disease cohort.
Yeaman F; Thin L
Therap Adv Gastroenterol; 2023; 16():17562848231167280. PubMed ID: 37153500
[TBL] [Abstract][Full Text] [Related]
22. Surveillance of patients with inflammatory bowel disease.
Yu JX; East JE; Kaltenbach T
Best Pract Res Clin Gastroenterol; 2016 Dec; 30(6):949-958. PubMed ID: 27938789
[TBL] [Abstract][Full Text] [Related]
23. High Adherence to Surveillance Guidelines in Inflammatory Bowel Disease Patients Results in Low Colorectal Cancer and Dysplasia Rates, While Rates of Dysplasia are Low Before the Suggested Onset of Surveillance.
Singh K; Al Khoury A; Kurti Z; Gonczi L; Reinglas J; Verdon C; Kohen R; Bessissow T; Afif W; Wild G; Seidman E; Bitton A; Lakatos PL
J Crohns Colitis; 2019 Sep; 13(10):1343-1350. PubMed ID: 30918959
[TBL] [Abstract][Full Text] [Related]
24. Colorectal polyps in ulcerative colitis and Crohn's colitis.
Fort Gasia M; Ghosh S; Iacucci M
Minerva Gastroenterol Dietol; 2015 Dec; 61(4):215-22. PubMed ID: 26446684
[TBL] [Abstract][Full Text] [Related]
25. Statin Exposure Is Not Associated with Reduced Prevalence of Colorectal Neoplasia in Patients with Inflammatory Bowel Disease.
Shah SC; Glass J; Giustino G; Hove JRT; Castaneda D; Torres J; Kumar A; Elman J; Ullman TA; Itzkowitz SH
Gut Liver; 2019 Jan; 13(1):54-61. PubMed ID: 30400722
[TBL] [Abstract][Full Text] [Related]
26. Chromoendoscopy for Dysplasia Surveillance in Inflammatory Bowel Disease.
Flynn AD; Valentine JF
Inflamm Bowel Dis; 2018 Jun; 24(7):1440-1452. PubMed ID: 29668929
[TBL] [Abstract][Full Text] [Related]
27. Real-life chromoendoscopy for neoplasia detection and characterisation in long-standing IBD.
Carballal S; Maisterra S; López-Serrano A; Gimeno-García AZ; Vera MI; Marín-Garbriel JC; Díaz-Tasende J; Márquez L; Álvarez MA; Hernández L; De Castro L; Gordillo J; Puig I; Vega P; Bustamante-Balén M; Acevedo J; Peñas B; López-Cerón M; Ricart E; Cuatrecasas M; Jimeno M; Pellisé M;
Gut; 2018 Jan; 67(1):70-78. PubMed ID: 27612488
[TBL] [Abstract][Full Text] [Related]
28. Dysplasia and colorectal cancer surveillance in inflammatory bowel disease.
Pulusu SSR; Lawrance IC
Expert Rev Gastroenterol Hepatol; 2017 Aug; 11(8):711-722. PubMed ID: 28475382
[TBL] [Abstract][Full Text] [Related]
29. Recent advances in surveillance colonoscopy for dysplasia in inflammatory bowel disease.
Na SY; Moon W
Clin Endosc; 2022 Nov; 55(6):726-735. PubMed ID: 36397275
[TBL] [Abstract][Full Text] [Related]
30. Systematic review with network meta-analysis: endoscopic techniques for dysplasia surveillance in inflammatory bowel disease.
Iannone A; Ruospo M; Palmer SC; Principi M; Barone M; Di Leo A; Strippoli GFM
Aliment Pharmacol Ther; 2019 Oct; 50(8):858-871. PubMed ID: 31502284
[TBL] [Abstract][Full Text] [Related]
31. Dysplasia and cancer in inflammatory bowel disease.
Basseri RJ; Basseri B; Papadakis KA
Expert Rev Gastroenterol Hepatol; 2011 Feb; 5(1):59-66. PubMed ID: 21309672
[TBL] [Abstract][Full Text] [Related]
32. Endoscopic factors in the diagnosis of colorectal dysplasia in chronic inflammatory bowel disease.
Toruner M; Harewood GC; Loftus EV; Sandborn WJ; Tremaine WJ; Faubion WA; Schroeder KW; Egan LJ
Inflamm Bowel Dis; 2005 May; 11(5):428-34. PubMed ID: 15867581
[TBL] [Abstract][Full Text] [Related]
33. Adherence to endoscopic surveillance guidelines for patients with inflammatory bowel disease: An Australian cohort study.
Picardo S; Venugopal K; Cheng W; Ragunath K
J Gastroenterol Hepatol; 2024 Mar; 39(3):506-511. PubMed ID: 38069495
[TBL] [Abstract][Full Text] [Related]
34. Clear liquid diet before bowel preparation predicts successful chromoendoscopy in patients with inflammatory bowel disease.
Megna B; Weiss J; Ley D; Saha S; Pfau P; Grimes I; Li Z; Caldera F
Gastrointest Endosc; 2019 Feb; 89(2):373-379.e2. PubMed ID: 30339950
[TBL] [Abstract][Full Text] [Related]
35. Advanced therapeutic endoscopist and inflammatory bowel disease: dawn of a new role.
Modha K; Navaneethan U
World J Gastroenterol; 2014 Apr; 20(13):3485-94. PubMed ID: 24707131
[TBL] [Abstract][Full Text] [Related]
36. Meta-analysis of Virtual-based Chromoendoscopy Compared With Dye-spraying Chromoendoscopy Standard and High-definition White Light Endoscopy in Patients With Inflammatory Bowel Disease at Increased Risk of Colon Cancer.
El-Dallal M; Chen Y; Lin Q; Rakowsky S; Sattler L; Foromera J; Grossberg L; Cheifetz AS; Feuerstein JD
Inflamm Bowel Dis; 2020 Aug; 26(9):1319-1329. PubMed ID: 32034916
[TBL] [Abstract][Full Text] [Related]
37. Yield of Random Biopsies During Colonoscopies in Inflammatory Bowel Disease Patients Undergoing Dysplasia Surveillance.
Hu AB; Burke KE; Kochar B; Ananthakrishnan AN
Inflamm Bowel Dis; 2021 May; 27(6):779-786. PubMed ID: 32812048
[TBL] [Abstract][Full Text] [Related]
38. Surveillance and management of colorectal dysplasia and cancer in inflammatory bowel disease: Current practice and future perspectives.
Wijnands AM; Mahmoud R; Lutgens MWMD; Oldenburg B
Eur J Intern Med; 2021 Nov; 93():35-41. PubMed ID: 34481721
[TBL] [Abstract][Full Text] [Related]
39. Colorectal cancer screening and surveillance in patients with inflammatory bowel disease in 2021.
Huguet JM; Ferrer-Barceló L; Suárez P; Sanchez E; Prieto JD; Garcia V; Sempere J
World J Gastroenterol; 2022 Feb; 28(5):502-516. PubMed ID: 35316962
[TBL] [Abstract][Full Text] [Related]
40. Colorectal Cancer Surveillance in Patients with Inflammatory Bowel Diseases: Chromoendoscopy or Non-Chromoendoscopy, That Is the Question.
Gabbiadini R; D'Amico F; De Marco A; Terrin M; Zilli A; Furfaro F; Allocca M; Fiorino G; Danese S
J Clin Med; 2022 Jan; 11(3):. PubMed ID: 35159961
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
